- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: tiotropium bromide inhalation powder HandiHaler
Total 550 results
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseGermany, Belgium, Colombia, Romania, South Africa, Italy, Hungary, Taiwan, Turkey, Switzerland, Australia, France, Israel, Sweden, China, Thailand, Estonia, Netherlands, Russian Federation, Slovakia, Spain, Argentina, Lithuania, Austria, Cana... and more
-
Boehringer IngelheimCompletedAsthmaGermany, Denmark, Netherlands
-
Laval UniversityBoehringer IngelheimCompletedChronic Obstructive Pulmonary DiseaseCanada
-
National Institute of Respiratory Diseases, MexicoCompleted
-
3MCompleted
-
Theron Pharmaceuticals, Inc.CompletedAsthmaUnited States
-
Boehringer IngelheimCompleted
-
AstraZenecaCompleted
-
National Jewish HealthNational Heart, Lung, and Blood Institute (NHLBI)CompletedObesity | AsthmaUnited States
-
Brigham and Women's HospitalMassachusetts General Hospital; Baim Institute for Clinical ResearchTerminated
-
University Medical Center GroningenRecruitingTuberculosisNetherlands
-
University of SaskatchewanRoyal University Hospital FoundationCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveSweden
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseGermany
-
University of DundeeAlmirall LimitedCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom
-
3MSimbec ResearchCompleted
-
The First Affiliated Hospital of Guangzhou Medical...Boehringer Ingelheim; Rundo International Pharmaceutical Research & Development...CompletedChronic Obstructive Pulmonary DiseaseChina
-
3MQuotient ClinicalCompleted
-
Boehringer IngelheimPfizerCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada
-
Mayo ClinicPfizer; Boehringer IngelheimCompletedChronic Obstructive Pulmonary Disease | COPDUnited States
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States, Spain, Switzerland, France, Italy, Germany, Turkey, Hungary, Norway, Slovakia, Poland, Russian Federation, Canada, Belgium, Austria, Colombia, Denmark, Finland, Greece, Israel, Mexico, United Kingdom
-
GlaxoSmithKlineCompleted
-
Boehringer IngelheimCompleted
-
Novartis PharmaceuticalsCompletedCOPDGermany, Spain, United Kingdom, Italy
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, United States, Netherlands, Czechia
-
Orion Corporation, Orion PharmaCompleted
-
Mannkind CorporationCompletedDiabetes, Type 2 | Diabetes, Type 1United States, Spain, Canada, Russian Federation, Czech Republic, Poland, Ukraine, United Kingdom
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveNetherlands
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Czechia
-
Yonsei UniversityNot yet recruitingChronic Obstructive Pulmonary DiseaseKorea, Republic of
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseSweden
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Belgium, Canada, Czech Republic, Denmark, Finland, Germany, South Africa, Spain, United Kingdom
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Australia, Canada, Denmark, Germany, Italy, Japan, Netherlands, New Zealand, Russian Federation, Serbia, South Africa, Turkey, Ukraine, United Kingdom
-
Eli Lilly and CompanyAlkermes, Inc.CompletedDiabetes Mellitus, Type 2Puerto Rico, United States, Spain, India, Belgium, Argentina, Austria, France, Mexico
-
National University of MalaysiaCompletedChronic Obstructive Pulmonary DiseaseMalaysia
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveBelgium, Canada, Netherlands, Germany
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveNetherlands, Belgium, United States
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Colombia, India, Korea, Republic of, Poland, Croatia, Estonia, Hungary, United Kingdom, Israel, Latvia, Turkey, Argentina, Panama, Mexico, Russian Federation, Serbia, Slovenia
-
National Institute of Respiratory Diseases, MexicoCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
University of California, Los AngelesMylan Pharmaceuticals Inc; Theravance BiopharmaRecruitingCOPD | Acute Respiratory FailureUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveJapan
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaTerminatedChronic Obstructive Pulmonary DiseaseItaly
-
Federal University of São PauloCompletedPulmonary Disease, Chronic Obstructive | Pulmonary Emphysema | Chronic BronchitisBrazil